SHH and breast ductal adenocarcinoma: Accordingly, we assessed the expression of Hh pathway members (GLI1, Shh and NF-κB) in 51 ductal breast carcinoma specimens by immunohistochemical analysis, and we correlated their expression with clinico-pathological variables.